v3.26.1
Statements of Cash Flows - CAD ($)
 3 Months Ended 12 Months Ended
Jun. 30, 2026
Jun. 30, 2025
Mar. 31, 2026
Operating activities      
Net income (loss) for the period $ 1,825,720 $ (379,029)  
Adjustments for:      
Amortization of right-of-use asset 7,114 5,044  
Equity-settled share-based compensation 61,567 62,265  
Interest expense - director's loans 24,932 0  
Office lease accretion per IFRS 16 3,152 730  
Office base rent recorded as lease reduction per IFRS 16 (10,549) (7,041)  
Transaction cost - director's loan 0 12,418  
Changes in non-cash working capital items      
Amounts receivable and other assets (49,250) (192,167)  
Accounts payable and accrued liabilities 357,986 1,593,720  
Advanced contributions received 922,236 1,639,235  
Due to related parties (104,663) 75,204  
Net cash provided by operating activities 3,038,245 2,810,379  
Financing activities      
Proceeds from option exercise 50,600 16,667  
Net cash provided by financing activities 50,600 16,667  
Net increase in cash for the period 3,088,845 2,827,046  
Cash, beginning balance 1,414,013 1,211,297 $ 1,211,297
Cash, Ending balance $ 4,502,858 $ 4,038,343 $ 1,414,013